 SAN DIEGO, March 02, 2021 GLOBE NEWSWIRE -- Metacrine, Inc. Nasdaq: MTCR, a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases, today announced that Preston Klassen, M.D., MHS, president and chief executive officer of Metacrine, will present at the H.C. Wainwright 2021 Global Life Sciences Conference, being held March 9-10, 2021. 